| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| menadione | aldehyde oxidase | NA | Successful target | TTD , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
0.45 | approved | unknown |
| menadione | osteocalcin | small molecule | NA | drugbank | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
NA | approved,nutraceutical | agonist |
| menadione | prothrombin | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
0.45 | approved,nutraceutical | activator |
| menadione | coagulation factor ix | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
0.57 | approved,nutraceutical | activator |
| menadione | vitamin k-dependent gamma-carboxylase | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
2.84 | approved,nutraceutical | cofactor |
| menadione | nad(p)h dehydrogenase [quinone] 1 | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
0.65 | approved,nutraceutical | unknown |
| menadione | ribosyldihydronicotinamide dehydrogenase [quinone] | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
0.91 | approved,nutraceutical | unknown |
| menadione | vitamin k-dependent protein c | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
1.14 | approved,nutraceutical | activator |
| menadione | vitamin k-dependent protein s | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
1.14 | approved,nutraceutical | activator |
| menadione | vitamin k epoxide reductase complex subunit 1 | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
1.24 | approved,nutraceutical | cofactor |
| menadione | vitamin k epoxide reductase complex subunit 1-like protein 1 | small molecule | NA | drugbank , DGIDB | Bone Mineralization[MeSHID:D002113] Blood coagulation[MeSHID:D001777] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Vitamin K Deficiency[MeSHID:D014813] Malignant neoplasm of prostate[MeSHID:D011471] |
6.82 | approved,nutraceutical | cofactor |
| click here to return to the previous page | ||||||||